Lymphokine‐activated killer (lak) cells discriminate between epstein‐barr virus (ebv)‐positive burkitt's lymphoma cells
- 15 September 1990
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 46 (3), 399-404
- https://doi.org/10.1002/ijc.2910460312
Abstract
We have generated in vitro lymphokine‐activated killer (LAK) cells from healthy donors by stimulating their mononuclear leukocytes with recombinant interleukin‐2 (rIL‐2) (100 U/ml). After 6 days in culture, the lytic properties of the LAK cells were analyzed in the 51Cr‐release assay by utilizing a target panel of 6 paired lines consisting of an Epstein‐Barr virus (EBV)‐positive Burkitt's lymphoma (BL) cell line and an EBV‐transformed lymphoblastoid cell line (LCL) from the same donor, the Raji BL line and the natural killer (NK) cell‐sensitive K562 line. The patterns of lysis showed that the LAK cells discriminated between two categories of BL cell lines. Group l/ll BL tumor cells which expressed the common acute lymphoblastic leukemia antigen (CALLA), the BL‐associated glycolipid antigen (BLA) and phenotypically resembled biopsy cells were strongly lysed whereas group III BL cells which had assumed an LCL‐like phenotype during culture and lacked the CALLA and BLA surface markers were only poorly lysed. The LCL targets were generally resistant to lysis but the K562 cell line was particularly sensitive. The outcome of cell depletion and monoclonal antibody (MAb) studies indicated that the LAK cell populations were phenotypically and functionally heterogeneous and consisted of at least 2 subpopulations of effector cells; a tumor‐specific component and an NK‐cell‐mediated component.This publication has 41 references indexed in Scilit:
- Antigen Presentation Requires Transport of MHC Class I Molecules from the Endoplasmic ReticulumScience, 1990
- Is suppression a function of class II- restricted cytotoxic T cells?Immunology Today, 1989
- Lymphokine‐activated killer‐cell function of lymphocytes from peripheral blood, regional lymph nodes and tumor tissues of patients with oral cancerInternational Journal of Cancer, 1989
- Why peptides? Their possible role in the evolution of MHC-restricted T-cell recognitionImmunology Today, 1989
- Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity.The Journal of Experimental Medicine, 1988
- Heterogeneity of lymphokyne-activated killer (LAK) populations at the clonal level: Both NK and CD3+, CD4−, CD8− clones efficiently mediate tumor cell killingClinical Immunology and Immunopathology, 1988
- Differential expression of hla antigen of HLA anigens on human B-cell lines of normal and malignant origin: A consequence of immune surveillance or a phenotypic vestige of the progenitor cells?International Journal of Cancer, 1988
- Absence, or low expression, of leukocyte adhesion molecules CDI1 and CD18 on burkjtt lymphoma cellsInternational Journal of Cancer, 1988
- Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance.The Journal of Experimental Medicine, 1988
- Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cellsNature, 1985